$MGLD
Marygold Companies, Inc. Stock $mgld

$mgld Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224044271 Filed on November 08, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2024 Q2
Revenue		$7.910M	$8.265M
YoY Change		-3.95%	-6.86%
Cost Of Revenue		$2.128M	$2.271M
YoY Change		4.46%	-1.31%
Gross Profit		$5.782M	$5.994M
YoY Change		-6.72%	-8.81%
Gross Profit Margin		73.1%	72.52%
Selling, General & Admin			$5.809M
YoY Change			16.03%
% of Gross Profit			96.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$159.0K	$146.0K
YoY Change		3.26%	3.99%
% of Gross Profit		2.75%	2.44%
Operating Expenses		$7.952M	$7.357M
YoY Change		9.92%	18.66%
Operating Profit		-$2.170M	-$1.363M
YoY Change		109.4%	-465.34%
Interest Expense			$172.0K
YoY Change			76.54%
% of Operating Profit
Other Income/Expense, Net		$101.0K	$184.0K
YoY Change		129.58%	-1446.01%
Pretax Income		-$2.069M	-$2.396M
YoY Change		157.72%	-624.47%
Income Tax		-$483.0K	-$539.0K
% Of Pretax Income
Net Earnings		-$1.586M	-$1.857M
YoY Change		217.09%	-658.04%
Net Earnings / Revenue		-20.05%	-22.47%
Basic Earnings Per Share		-$0.04
Diluted Earnings Per Share		-$0.04	-$0.05
COMMON SHARES
Basic Shares Outstanding	40.33M shares	40.85M shares	39.38M shares
Diluted Shares Outstanding		40.85M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$15.01M
YoY Change		-23.57%
Cash & Equivalents	$6.665M	$5.461M
Short-Term Investments		$9.551M
Other Short-Term Assets	$1.096M	$3.034M
YoY Change	12.58%	235.56%
Inventory	$2.175M	$2.191M
Prepaid Expenses
Receivables	$2.507M	$2.678M
Other Receivables		$0.00
Total Short-Term Assets	$25.00M	$24.25M
YoY Change	-8.38%	-9.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.144M	$1.166M
YoY Change	-40.14%	-43.84%
Goodwill	$2.481M	$2.481M
YoY Change	7.53%	7.53%
Intangibles	$1.296M	$1.375M
YoY Change	-41.64%	-40.99%
Long-Term Investments
YoY Change
Other Assets	$2.402M	$619.0K
YoY Change	334.63%	12.0%
Total Long-Term Assets	$10.87M	$8.646M
YoY Change	32.99%	2.17%
TOTAL ASSETS
Total Short-Term Assets	$25.00M	$24.25M
Total Long-Term Assets	$10.87M	$8.646M
Total Assets	$35.88M	$32.90M
YoY Change	1.16%	-6.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.997M	$1.955M
YoY Change	-18.48%	47.49%
Accrued Expenses	$1.207M	$1.185M
YoY Change	87.62%	42.06%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$333.0K
YoY Change		-7.19%
Total Short-Term Liabilities	$7.874M	$5.233M
YoY Change	60.33%	24.84%
LONG-TERM LIABILITIES
Long-Term Debt		$70.00K
YoY Change		-20.92%
Other Long-Term Liabilities		$622.0K
YoY Change		63.45%
Total Long-Term Liabilities	$2.470M	$1.052M
YoY Change	264.75%	47.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.874M	$5.233M
Total Long-Term Liabilities	$2.470M	$1.052M
Total Liabilities	$10.34M	$6.285M
YoY Change	85.1%	28.19%
SHAREHOLDERS EQUITY
Retained Earnings	$12.43M	$14.02M
YoY Change	-29.31%	-22.49%
Common Stock	$40.00K	$40.00K
YoY Change	1.56%	1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.53M	$26.61M
YoY Change
Total Liabilities & Shareholders Equity	$35.88M	$32.90M
YoY Change	1.16%	-6.75%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$1.586M	-$1.857M
YoY Change	217.09%	-658.04%
Depreciation, Depletion And Amortization	$159.0K	$146.0K
YoY Change	3.26%	3.99%
Cash From Operating Activities	-$893.0K	-$695.0K
YoY Change	-405.46%	-167.33%
INVESTING ACTIVITIES
Capital Expenditures	$47.00K	$24.00K
YoY Change	86.59%	15.66%
Acquisitions
YoY Change
Other Investing Activities		$1.853M
YoY Change		-164.47%
Cash From Investing Activities	-$1.325M	$1.829M
YoY Change	-13.77%	-163.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.375M	-13.00K
YoY Change	-92414.0%	225.0%
NET CHANGE
Cash From Operating Activities	-$893.0K	-695.0K
Cash From Investing Activities	-$1.325M	1.829M
Cash From Financing Activities	$3.375M	-13.00K
Net Change In Cash	$1.206M	1.121M
YoY Change	-201.71%	-160.06%
FREE CASH FLOW
Cash From Operating Activities	-$893.0K	-$695.0K
Capital Expenditures	$47.00K	$24.00K
Free Cash Flow	-$940.0K	-$719.0K
YoY Change	-451.85%	-171.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1133909
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	120 Calle Iglesia
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit B
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q3	dei	City Area Code CityAreaCode	949
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	429-5370
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2024Q3	dei	Trading Symbol TradingSymbol	MGLD
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40326035	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6665000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	2175000	usd
CY2024Q3	us-gaap	Prepaid Taxes PrepaidTaxes	1751000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	10807000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1096000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	25001000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	64000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1144000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1518000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1296000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1969000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2402000	usd
CY2024Q3	us-gaap	Assets Assets	35875000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4125000	usd
CY2024Q3	MGLD	Purchase Consideration Payable PurchaseConsiderationPayable	251000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7874000	usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	910000	usd
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	dei	Entity File Number EntityFileNumber	001-41318
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	THE MARYGOLD COMPANIES, INC.
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92672
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001005101
CY2024Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q3	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2023Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q3	MGLD	Original Issue Discount And Loan Fee Added To Note Payable Balance OriginalIssueDiscountAndLoanFeeAddedToNotePayableBalance		usd
CY2023Q3	MGLD	Acquisition Of Operating Rightofuse Assets Through Operating Lease Liabilities AcquisitionOfOperatingRightofuseAssetsThroughOperatingLeaseLiabilities		usd
CY2024Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2024Q2	us-gaap	Long Term Investments LongTermInvestments		usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax		usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax		usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2024Q3	MGLD	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour		usd
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M24D
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5461000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2507000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2678000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2191000	usd
CY2024Q2	us-gaap	Prepaid Taxes PrepaidTaxes	1338000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	9551000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	3034000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	24253000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	62000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1166000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	974000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	2481000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2481000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1375000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1969000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	619000	usd
CY2024Q2	us-gaap	Assets Assets	32899000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4021000	usd
CY2024Q3	MGLD	Lease Liabilities Current Portion LeaseLiabilitiesCurrentPortion	698000	usd
CY2024Q2	MGLD	Lease Liabilities Current Portion LeaseLiabilitiesCurrentPortion	620000	usd
CY2024Q2	MGLD	Purchase Consideration Payable PurchaseConsiderationPayable	277000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2800000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	315000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5233000	usd
CY2024Q3	MGLD	Purchase Consideration Payable Noncurrent PurchaseConsiderationPayableNoncurrent	251000	usd
CY2024Q2	MGLD	Purchase Consideration Payable Noncurrent PurchaseConsiderationPayableNoncurrent	237000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	949000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	455000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	360000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	360000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2470000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1052000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	10344000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	6285000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40326000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40326000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40096000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40096000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13285000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12825000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-226000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-269000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12432000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14018000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	25531000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	26614000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35875000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32899000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7910000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8235000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	2128000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2037000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	5782000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	6198000	usd
CY2024Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3147000	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2590000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2565000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2248000	usd
CY2024Q3	MGLD	Fund Operations FundOperations	1412000	usd
CY2023Q3	MGLD	Fund Operations FundOperations	1270000	usd
CY2024Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	669000	usd
CY2023Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	972000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	159000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	154000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	7952000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	7234000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2170000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1036000	usd
CY2024Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	151000	usd
CY2023Q3	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	193000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	31000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	101000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	233000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2069000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-803000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-483000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-303000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1586000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40848000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40848000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1586000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	43000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-94000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1543000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-594000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	26614000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	43000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	460000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1586000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	25531000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30378000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30378000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-94000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-94000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	29877000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	29877000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1586000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-500000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	159000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	460000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	93000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-22000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	269000	usd
CY2024Q3	us-gaap	Other Noncash Expense OtherNoncashExpense	20000	usd
CY2024Q3	MGLD	Noncash Lease Costs NoncashLeaseCosts	-164000	usd
CY2023Q3	MGLD	Noncash Lease Costs NoncashLeaseCosts	-128000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-172000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-482000	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	415000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	359000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-155000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	70000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	73000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	717000	usd
CY2024Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-164000	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-119000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-893000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	291000	usd
CY2024Q3	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	298000	usd
CY2023Q3	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	7830000	usd
CY2024Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1576000	usd
CY2023Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	9341000	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1325000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1536000	usd
CY2024Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3690000	usd
CY2024Q3	MGLD	Repayment Of Mortgage Loan Payable RepaymentOfMortgageLoanPayable	315000	usd
CY2023Q3	MGLD	Repayment Of Mortgage Loan Payable RepaymentOfMortgageLoanPayable	2000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3375000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2000	usd
CY2024Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	62000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1206000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1185000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5523000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8586000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6729000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7401000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6665000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6987000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	64000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	414000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6729000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7401000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	5000	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13000	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	87000	usd
CY2024Q3	MGLD	Original Issue Discount And Loan Fee Added To Note Payable Balance OriginalIssueDiscountAndLoanFeeAddedToNotePayableBalance	380000	usd
CY2024Q3	MGLD	Acquisition Of Operating Rightofuse Assets Through Operating Lease Liabilities AcquisitionOfOperatingRightofuseAssetsThroughOperatingLeaseLiabilities	691000	usd
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z3vsFrbrbCv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zdLZ53ftUD2k">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zCuAIR81CYb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zR2nSiTGCMve">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our subsidiary USCF Investments relies on the revenues generated through the various funds it manages. The concentration of fund management revenue and related receivables were (dollars in thousands):</span></p> <p id="xdx_898_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zoNi6NoFcLUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zH49hdlTo1Uj" style="display: none">SCHEDULE OF CONCENTRATION RISK</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">Quarters Ended September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="14"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accounts Receivable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Fund</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 20%">USO</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--WainwrightMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z0ssYctM815h" style="width: 5%; text-align: right">1,432</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zYLXZaLsmteb" style="width: 5%; text-align: right">31</td><td style="width: 2%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zXhgy6ehCHAc" style="width: 5%; text-align: right">1,684</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zSUUiTZ3oXga" style="width: 5%; text-align: right">33</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zYkp9HzwBn51" style="width: 7%; text-align: right" title="Accounts receivable">491</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zzwkfbXCaBFi" style="width: 7%; text-align: right" title="Concentration risk percentage">31</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zmQNfmpl2ygb" style="width: 7%; text-align: right" title="Accounts receivable">473</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUSOFundMember_zL3BcrOKmpuc" style="width: 7%; text-align: right" title="Concentration risk percentage">33</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>UNG</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zrSmHt9yFY01" style="text-align: right">1,206</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_z6a1FXcK6s0e" style="text-align: right">26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zwg3ksoT6Io3" style="text-align: right">1,689</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_z1mFbVtjpOaf" style="text-align: right">34</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zd6HnW7Gyj7h" style="text-align: right" title="Accounts receivable">432</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zYALs3MS7qKg" style="text-align: right" title="Concentration risk percentage">27</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_zXQsqfExgnL7" style="text-align: right" title="Accounts receivable">370</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUNGFundMember_z23B9SD0oeAj" style="text-align: right" title="Concentration risk percentage">25</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>UMI</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_zSkbUg6DQ8Uc" style="text-align: right">635</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_z0KEJqctr0D9" style="text-align: right">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_987_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_z4yyKZGTi1s4" style="font: 10pt Times New Roman, Times, Serif; margin: 0">454</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_zo4jAVTSzYYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0">9</p></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_zcuPp5kk1Xni" style="text-align: right" title="Accounts receivable">216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_zskhwPaEdjge" style="text-align: right" title="Concentration risk percentage">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_z42sIZ1b5iEi" style="text-align: right" title="Accounts receivable">185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--CustomersRelatedToTheUMIFundMember_zK2vozUl8Xvg" style="text-align: right" title="Concentration risk percentage">13</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">All Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zSKo6Z6VyeZk" style="border-bottom: Black 1pt solid; text-align: right">1,318</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zpghmxUd1HTh" style="border-bottom: Black 1pt solid; text-align: right">29</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zgLuv9oEzvrb" style="border-bottom: Black 1pt solid; text-align: right">1,222</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zHxxgjOSg98g" style="border-bottom: Black 1pt solid; text-align: right">24</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zh1YLaFpRp4b" style="border-bottom: Black 1pt solid; text-align: right" title="Accounts receivable">439</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zAuYItx2vB9l" style="border-bottom: Black 1pt solid; text-align: right" title="Concentration risk percentage">28</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zbTroZtVhUXf" style="border-bottom: Black 1pt solid; text-align: right" title="Accounts receivable">427</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember__srt--MajorCustomersAxis__custom--AllOtherCustomersMember_zlHhBD1VvRXh" style="border-bottom: Black 1pt solid; text-align: right" title="Concentration risk percentage">29</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_zLf6zXecKMY8" style="border-bottom: Black 2.5pt double; text-align: right">4,591</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_zg9RyWgbYUx7" style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_zhTFdvtawzh5" style="border-bottom: Black 2.5pt double; text-align: right">5,049</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_za8PdJsW9C9c" style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_z05RVBrECJK" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable">1,578</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_zcRVQPzI6s2" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AccountsReceivableNetCurrent_iI_pn3n3_c20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_z1qhDSwjfY16" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable">1,455</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--USCFInvestmentsIncMember_zEExHzWn1v53" style="border-bottom: Black 2.5pt double; text-align: right" title="Concentration risk percentage">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AB_zXNgt0X2j423" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are no significant concentrations for the other operating subsidiaries on a consolidated basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1100000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1300000	shares
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1548000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1548000	usd
CY2024Q3	MGLD	Weighted Average Number Of Shares Outstanding Common Stock Basic WeightedAverageNumberOfSharesOutstandingCommonStockBasic	39861000	shares
CY2024Q3	MGLD	Weighted Average Numberof Shares Outstanding Common Stock Diluted WeightedAverageNumberofSharesOutstandingCommonStockDiluted	39861000	shares
CY2024Q3	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders	-0.04
CY2024Q3	MGLD	Earnings Per Share Diluted Common Shareholders EarningsPerShareDilutedCommonShareholders	-0.04
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-488000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-488000	usd
CY2023Q3	MGLD	Weighted Average Number Of Shares Outstanding Common Stock Basic WeightedAverageNumberOfSharesOutstandingCommonStockBasic	39410000	shares
CY2023Q3	MGLD	Weighted Average Numberof Shares Outstanding Common Stock Diluted WeightedAverageNumberofSharesOutstandingCommonStockDiluted	39410000	shares
CY2023Q3	MGLD	Earnings Per Share Basic Common Shareholders EarningsPerShareBasicCommonShareholders	-0.01
CY2023Q3	MGLD	Earnings Per Share Diluted Common Shareholders EarningsPerShareDilutedCommonShareholders	-0.01
CY2024Q3	MGLD	Net Income Loss Available To Preferred Stockholders Basic NetIncomeLossAvailableToPreferredStockholdersBasic	-38000	usd
CY2024Q3	MGLD	Net Income Loss Available To Preferred Stockholders Diluted NetIncomeLossAvailableToPreferredStockholdersDiluted	-38000	usd
CY2024Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock Basic WeightedAverageNumberOfSharesOutstandingPreferredStockBasic	987000	shares
CY2024Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock Diluted WeightedAverageNumberOfSharesOutstandingPreferredStockDiluted	987000	shares
CY2024Q3	MGLD	Earnings Per Share Basic Preferred Shareholders EarningsPerShareBasicPreferredShareholders	-0.04
CY2024Q3	MGLD	Earnings Per Share Diluted Preferred Shareholders EarningsPerShareDilutedPreferredShareholders	-0.04
CY2023Q3	MGLD	Net Income Loss Available To Preferred Stockholders Basic NetIncomeLossAvailableToPreferredStockholdersBasic	-12000	usd
CY2023Q3	MGLD	Net Income Loss Available To Preferred Stockholders Diluted NetIncomeLossAvailableToPreferredStockholdersDiluted	-12000	usd
CY2023Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock Basic WeightedAverageNumberOfSharesOutstandingPreferredStockBasic	987000	shares
CY2023Q3	MGLD	Weighted Average Number Of Shares Outstanding Preferred Stock Diluted WeightedAverageNumberOfSharesOutstandingPreferredStockDiluted	987000	shares
CY2023Q3	MGLD	Earnings Per Share Basic Preferred Shareholders EarningsPerShareBasicPreferredShareholders	-0.01
CY2023Q3	MGLD	Earnings Per Share Diluted Preferred Shareholders EarningsPerShareDilutedPreferredShareholders	-0.01
CY2024Q3	MGLD	Net Income Loss Attributable To Parent Basic NetIncomeLossAttributableToParentBasic	-1586000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1586000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40848000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40848000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q3	MGLD	Net Income Loss Attributable To Parent Basic NetIncomeLossAttributableToParentBasic	-500000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-500000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40397000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40397000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q3	MGLD	Deposit Restricted Relating To Account For Fintech App DepositRestrictedRelatingToAccountForFintechApp	52000	usd
CY2024Q2	MGLD	Deposit Restricted Relating To Account For Fintech App DepositRestrictedRelatingToAccountForFintechApp	50000	usd
CY2024Q3	MGLD	Deposit For Securing Lease Bond DepositForSecuringLeaseBond	12000	usd
CY2024Q2	MGLD	Deposit For Securing Lease Bond DepositForSecuringLeaseBond	12000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	64000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	62000	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1800000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1096000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1234000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1096000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	3034000	usd
CY2024Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1379000	usd
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1417000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	796000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	774000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	2175000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2191000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3344000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3337000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2200000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2171000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1144000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1166000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	100000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	100000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	2481000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2481000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	2481000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	2481000	usd
CY2024Q3	us-gaap	Long Term Investments LongTermInvestments	1800000	usd
CY2024Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	502000	usd
CY2024Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	502000	usd
CY2024Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	100000	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	117000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2402000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	619000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1997000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1955000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1207000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1185000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	844000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	736000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	77000	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	145000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4125000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4021000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	10734000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	73000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	10807000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9477000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	74000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	9551000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2403000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1107000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1296000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2403000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1028000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1375000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	240000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	290000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	147000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	147000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	147000	usd
CY2024Q3	MGLD	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	325000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1296000	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	3700000	usd
CY2024Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.413	pure
CY2024Q3	us-gaap	Share Price SharePrice	1.34
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.37	pure
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.045	pure
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	500000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	100000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	200000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	200000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	607000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	15000	usd
CY2024Q3	MGLD	Lease Liability Payments Remainder Of Fiscal Year LeaseLiabilityPaymentsRemainderOfFiscalYear	622000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	596000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	20000	usd
CY2024Q3	MGLD	Lease Liability Payments Due Next Twelve Months LeaseLiabilityPaymentsDueNextTwelveMonths	616000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	338000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	20000	usd
CY2024Q3	MGLD	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	358000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	155000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	20000	usd
CY2024Q3	MGLD	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	175000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	20000	usd
CY2024Q3	MGLD	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	20000	usd
CY2024Q3	MGLD	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	48000	usd
CY2024Q3	MGLD	Lease Liability Payments Due After Year Four LeaseLiabilityPaymentsDueAfterYearFour	48000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1696000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	143000	usd
CY2024Q3	MGLD	Lease Liability Payments Due LeaseLiabilityPaymentsDue	1839000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	161000	usd
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	31000	usd
CY2024Q3	MGLD	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	192000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1535000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	112000	usd
CY2024Q3	MGLD	Lease Liability Cost LeaseLiabilityCost	1647000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.057	pure
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.070	pure
CY2024Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
CY2023Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	100000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-044271-index-headers.html	Edgar Link	pending
0001493152-24-044271-index.html	Edgar Link	pending
0001493152-24-044271.txt	Edgar Link	pending
0001493152-24-044271-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mgld-20240930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
mgld-20240930_cal.xml	Edgar Link	unprocessable
mgld-20240930_def.xml	Edgar Link	unprocessable
mgld-20240930_lab.xml	Edgar Link	unprocessable
mgld-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGLD
Marygold Companies, Inc. Stock $mgld

2024 Q4 Form 10-Q Financial Statement

#000149315224044271 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGLD Marygold Companies, Inc. Stock $mgld

2024 Q4 Form 10-Q Financial Statement

#000149315224044271 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGLD
Marygold Companies, Inc. Stock $mgld